Literature DB >> 9492712

Glucose intolerance in women with preeclampsia.

B Lorentzen1, K I Birkeland, M J Endresen, T Henriksen.   

Abstract

BACKGROUND: We have previously shown that women with proteinuric hypertension of pregnancy (preeclampsia) have increased circulating levels of triglycerides and free fatty acids. Preeclampsia has, therefore, several features in common with the insulin resistance syndrome. The objective of the present study was to investigate the glucose tolerance and insulin response of women with preeclampsia compared to women with normal pregnancy.
METHODS: Oral glucose tolerance test was performed in ten women with preeclampsia and eight healthy women with normal pregnancy. The glucose, insulin, C-peptide and free fatty acid responses were calculated.
RESULTS: The mean fasting glucose concentration was significantly lower in preeclamptic women (3.3 vs 3.7 mmol/l; p = 0.02). Fasting serum triglycerides were increased in women with preeclampsia compared to normal pregnancy (3.3 vs 1.9 mmol/l; p = 0.003). Women with preeclampsia had also increased serum free fatty acids, 0.52 vs 0.36 mmol/l for normal pregnancy; p = 0.056). Log s-insulin and cholesterol were not different. The incremental area under the curve for the glucose (p = 0.001) and insulin (p = 0.02) responses to oral glucose tolerance test showed higher values for preeclampsia as compared to women with normal pregnancy. For free fatty acids the total area under the suppression curve was higher in women with preeclampsia (p = 0.03).
CONCLUSIONS: These results support the concept that preeclampsia is associated with metabolic aberrations found in insulin resistance syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9492712

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  9 in total

1.  Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.

Authors:  Piya Chaemsaithong; Roberto Romero; Adi L Tarca; Steven J Korzeniewski; Alyse G Schwartz; Jezid Miranda; Ahmed I Ahmed; Zhong Dong; Sonia S Hassan; Lami Yeo; Tinnakorn Tinnakorn
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

2.  Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2010-03       Impact factor: 8.661

3.  Impaired proliferation of pancreatic beta cells, by reduced placental growth factor in pre-eclampsia, as a cause for gestational diabetes mellitus.

Authors:  Jun Li; Huanchun Ying; Guiyang Cai; Quan Guo; Lizhu Chen
Journal:  Cell Prolif       Date:  2015-01-16       Impact factor: 6.831

4.  Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study.

Authors:  Masako Tanaka; Gundegmaa Jaamaa; Michelle Kaiser; Elaine Hills; Aida Soim; Motao Zhu; Ivan Y Shcherbatykh; Renee Samelson; Erin Bell; Michael Zdeb; Louise-Anne McNutt
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

5.  The effect of maternal body mass index on perinatal outcomes in women with diabetes.

Authors:  Nicole E Marshall; Camelia Guild; Yvonne W Cheng; Aaron B Caughey; Donna R Halloran
Journal:  Am J Perinatol       Date:  2013-05-21       Impact factor: 1.862

6.  Effect of preeclampsia on insulin sensitivity.

Authors:  Smita Sinha; Gobind Pratap Singh; Kapil Gupta; Satwant Kumar; Aekta Gupta
Journal:  Int J Appl Basic Med Res       Date:  2014-01

Review 7.  Androgens in maternal vascular and placental function: implications for preeclampsia pathogenesis

Authors:  Sathish Kumar; Geoffrey H Gordon; David H Abbott; Jay S Mishra
Journal:  Reproduction       Date:  2018-10-16       Impact factor: 3.906

8.  Insulin changes in preeclamptic women during pregnancy.

Authors:  Shohreh Malek-Khosravi; Bijan Kaboudi
Journal:  Ann Saudi Med       Date:  2004 Nov-Dec       Impact factor: 1.526

9.  Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.

Authors:  Jialyu Huang; Jiaying Lin; Leizhen Xia; Lifeng Tian; Dingfei Xu; Peipei Liu; Jing Zhu; Qiongfang Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-29       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.